References
- Weinreb RN. A rationale for lowering intraocular pressure in glaucoma. Surv Ophthalmol 2001;45(Suppl 4):S335–S336
- AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:490–1
- European Glaucoma Society. Terminology and guidelines for glaucoma, 2nd ed. Savona, Italy: Editrice Dogma; 2003
- Rouland JF, Hågå A, Bengtsson S, et al. What triggers change of therapy? In: Jønsson B, Krieglstein G, editors. Primary open-angle glaucoma. Differences in international treatment patterns and costs. Oxford: Isis Medical Media Ltd.; 1999. p. 162–8
- Marchetti A, Magar R, An P, et al. Clinical and economic impact of new trends in glaucoma treatment. Med Gen Med 2001;3:6
- Strutton DR, Walt JG. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma 2004;13:221–6
- Whittaker KW, Gillow JT, Cunliffe IA. Is the role of trabeculectomy in glaucoma management changing? Eye 2001;15:49–452
- Bateman DN, Clark R, Azuara-Blanco A, et al. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol 2002;86:551–4
- Hurst J, Siciliani L. Tackling excessive waiting times for elective surgery: a comparison of policies in twelve OECD countries [OECD Health Working Papers 6]. Paris: OECD; 2003
- Vetrugno M, Sborgia C, Balestrazzi E, et al. Efficacy and safety of bimatoprost in patients with uncontrolled glaucoma as alternative to filtration surgery. Eur J Ophthalmol 2005;15:477–81
- Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943–53
- Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997;6:217–27
- Keeler K. Decision trees and Markov models in cost-effectiveness research [Chapter 9] In: Sloan FA, editor. Valuing health care. Cambridge University Press; 1995
- Kobelt G, Jonsson L, Gerdtham U, Krieglstein GK. Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany. Graefe's Arch Clin Exp Ophthalmol 1998;236:811–21
- Kobelt G, Jonsson L. Modeling cost of treatment with new topical treatments for glaucoma. Results from France and the United Kingdom. Int J Technol Assess Health Care 1999;15:207–19
- Garattini L, Grilli R, Scopelliti D, Mantovani L. A proposal for Italian guidelines in pharmacoeconomics. Pharmacoeconomics 1995;7:1–6
- Duffield C. The Delphi technique: a comparison of results obtained using two expert panels. Int J Nurs Stud 1993;30:227–37
- Ziglio E. The Delphi method and its contribution to decision making. In: Adler M, Ziglio E, editors. Gazing into the oracle: the Delphi method and its application to social policy and public health. London: Jessica Kingsley Publishers; 1996. p. 3–33
- Sonnenberg FA, Beck JR. Markov models in medical decision making. A practical guide. Med Decis Mak 1993;13:322–38
- Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397–409
- Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Am J Ophthalmol 1995;120:718–31
- Tuil E, Hommer AB, Poulsen PB, et al. The cost-effectiveness of bimatoprost 0.03% in the treatment of glaucoma in adult patients – a European perspective. Int J Clin Pract 2005;59: 1011–6
- Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study. Interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 2001;108:1954–65
- Garrison L, Towse A. The drug budget silo mentality in Europe: an overview. Value Health 2003;6(S1):S1–S9
- Drummond M, Jönsson B. Moving beyond the drug budget silo mentality in Europe. Value Health 2003;6(S1):S74–S77